Ladenburg Thalmann Downgrades Spruce Biosciences, Inc. (SPRB) to Neutral, 'Regulatory Path Unclear'
Tweet Send to a Friend
Ladenburg Thalmann analyst Aydin Huseynov downgraded Spruce Biosciences, Inc. (NASDAQ: SPRB) from Buy to Neutral.The analyst comments "Yesterday, SPRB announced ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
